Latest news with #JonathanRigby
Globe and Mail
3 days ago
- Business
- Globe and Mail
Sernova Appoints Jonathan Rigby as Interim Chair
LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its Cell Pouch Bio-hybrid Organ as a functional cure for type 1 diabetes (T1D), today announced the appointment of Sernova's Chief Executive Officer Jonathan Rigby as Interim Chair of the board of directors. Mr. Rigby will assume the Chair role, effective immediately, until a new independent director is appointed to serve as the next Chair of the Board. Sernova continues to advance financing discussions as previously disclosed with GoldTrack Ventures and the Kingdom of Saudi Arabia, regarding a potential investment and continues to believe that this will be a promising partnership. 'Sernova is making significant strides on multiple strategic and operational fronts. The recent release of encouraging clinical data, formation of a world-class Clinical Advisory Board, and active investment discussions with multiple parties is encouraging,' said Jonathan Rigby, Interim Chair and Chief Executive Officer of Sernova. 'As we advance toward our goal of delivering a functional cure for type 1 diabetes, we remain focused on execution and creating long-term shareholder value.' Sernova also announced the departure of Modestus Obochi, its Chief Business Officer. The company thanks Dr. Obochi for his leadership and contributions during his tenure and wishes him well in his future endeavors. ABOUT SERNOVA BIOTHERAPEUTICS Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem-cell derived islet like clusters in collaboration with Evotec to create Bio-hybrid Organs to treat T1D. A Bio-hybrid Organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This innovative approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on T1D and thyroid disorders. FOR FURTHER INFORMATION, PLEASE CONTACT: David Burke VP, Investor Relations (917) 751-5713 Email: Website: The TSX has not reviewed this news release and does not accept responsibility for the accuracy or adequacy of this news release. FORWARD-LOOKING INFORMATION This press release contains forward-looking statements within the meaning of applicable Canadian securities laws. Forward-looking statements in this press release include the potential to finalize an agreement with GoldTrack Ventures to provide funding for operations. With respect to the forward-looking statements contained in this press release, Sernova has made numerous assumptions regarding, among other things: the company's ability to secure additional financing on reasonable terms, or at all; and the ability to conduct all required preclinical and clinical studies for the company's Cell Pouch, including the timing and results of those trials. A more complete discussion of the risks and uncertainties facing Sernova appears in Sernova's Annual Information Form for the year ended October 31, 2024, filed with Canadian securities authorities and available at as updated by Sernova's continuous disclosure filings, which are available at All forward-looking statements herein are qualified in their entirety by this cautionary statement, and Sernova disclaims any obligation to revise or update any such forward-looking statements or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments, except as required by law.
Yahoo
09-02-2025
- Yahoo
Tragedy as Bolton dad, 47, who had moved to 'live out his dreams' is killed in horror crash
A dad from Bolton was tragically killed in a horror crash in north Wales after moving there to 'fulfil his dreams' with his wife. Jonathan Rigby, 47, was killed when the motorbike he was riding was hit by a Volkswagen Tiguan on January 30. Police and paramedics raced to the scene of the smash, on the A487 near Bangor. Jonathan was rushed to hospital but was later pronounced dead. The driver of the car was arrested on suspicion of causing death by dangerous driving and has been released under investigation. Jonathan's family revealed that the dad and grandad had moved to Anglesey to 'live out his dreams' with his wife before he was killed. They have paid an emotional tribute to him following his death. They said in a statement: 'Jon Rigby was a 47-year-old, music-loving, healthy, active man, devoted husband and father to their daughter, sons and grandfather to their two granddaughters. 'Jon had recently moved to Anglesey to live out his dreams with his loving wife but tragically, this is now no longer a possibility. As a family, we now need time to grieve the man we have lost and the future we will now no longer be able to have.'We would all like to pass on our sincere thanks to all the first responders, off duty doctors and nurses and by-standers who provided medical assistance in such a difficult situation. We would also like to pass on our thanks to North Wales Police for all their assistance.' In an emotional post on social media, the family added: "Tragically and suddenly, in a road traffic collision on Thursday 30th January, our worlds were ripped apart. The heart of our family was so cruelly taken from us." Police are continuing to appeal for witnesses to the collision on top of the A487 Faenol Hill, near to the junction of Penrhos Road and involved a Honda motorcycle – being ridden by Mr Rigby, and a grey-coloured Volkswagen Liam Morris of the Serious Collision Investigation Unit said: 'We continue to urge anybody who may have witnessed the collision and are yet to speak to us, or anybody who may have been travelling along the A487 around the time of the collision, or just prior, to contact us.'Anybody with information that could assist with the ongoing investigation is urged to contact officers at the Serious Collision Investigation Unit via the website or by calling 101, quoting reference number 25000079908.
